1. Home
  2. ABP vs UAMY Comparison

ABP vs UAMY Comparison

Compare ABP & UAMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABP
  • UAMY
  • Stock Information
  • Founded
  • ABP 2004
  • UAMY 1968
  • Country
  • ABP United States
  • UAMY United States
  • Employees
  • ABP N/A
  • UAMY N/A
  • Industry
  • ABP Biotechnology: Pharmaceutical Preparations
  • UAMY Metal Fabrications
  • Sector
  • ABP Health Care
  • UAMY Industrials
  • Exchange
  • ABP Nasdaq
  • UAMY Nasdaq
  • Market Cap
  • ABP 78.8M
  • UAMY 74.2M
  • IPO Year
  • ABP N/A
  • UAMY N/A
  • Fundamental
  • Price
  • ABP $1.10
  • UAMY $1.80
  • Analyst Decision
  • ABP
  • UAMY Strong Buy
  • Analyst Count
  • ABP 0
  • UAMY 2
  • Target Price
  • ABP N/A
  • UAMY $1.75
  • AVG Volume (30 Days)
  • ABP 47.0K
  • UAMY 7.9M
  • Earning Date
  • ABP 04-03-2025
  • UAMY 11-12-2024
  • Dividend Yield
  • ABP N/A
  • UAMY N/A
  • EPS Growth
  • ABP N/A
  • UAMY N/A
  • EPS
  • ABP N/A
  • UAMY N/A
  • Revenue
  • ABP $122,000.00
  • UAMY $10,219,826.00
  • Revenue This Year
  • ABP N/A
  • UAMY N/A
  • Revenue Next Year
  • ABP N/A
  • UAMY N/A
  • P/E Ratio
  • ABP N/A
  • UAMY N/A
  • Revenue Growth
  • ABP N/A
  • UAMY 28.40
  • 52 Week Low
  • ABP $1.09
  • UAMY $0.17
  • 52 Week High
  • ABP $13.00
  • UAMY $2.35
  • Technical
  • Relative Strength Index (RSI)
  • ABP N/A
  • UAMY 63.77
  • Support Level
  • ABP N/A
  • UAMY $1.30
  • Resistance Level
  • ABP N/A
  • UAMY $2.35
  • Average True Range (ATR)
  • ABP 0.00
  • UAMY 0.33
  • MACD
  • ABP 0.00
  • UAMY 0.08
  • Stochastic Oscillator
  • ABP 0.00
  • UAMY 66.16

About ABP Abpro Holdings Inc Common Stock

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with global pharmaceutical and research institutions.

About UAMY United States Antimony Corporation

United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has four operating segments: United States Antimony, Mexican antimony, zeolite, and Precious metals. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.

Share on Social Networks: